Nephrology Medical News about Rituximab

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rituximab therapy in nephrotic syndrome due to AH amyloidosis
Amyloid The Journal of Protein Folding Disorders, 08/26/09

Katoh N et al. – The authors report a patient with AH amyloidosis associated with lymphoplasmacytic leukemia that has remained in a stable state with a nephrotic syndrome for 17 months since the commencement of cyclic rituximab therapy aimed at suppression of pathogenetic gamma heavy chains. Rituximab might be a potent therapeutic option for AH amyloidosis associated with a B–cell lymphoproliferative disorder.

<< Previous
Idiopathic Retroperitoneal Fibrosis: Prospective Evaluation of...

Next >>
Comparison of 1.5 and 3 T BOLD MR to Study Oxygenation of Kidney...

Treatment of adult inflammatory myositis with rituximab: An emerging therapy for refractory patients
Journal of Clinical Rheumatology (JCR), 10/08/09 Relevance Score: 90%

Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection
Nephrology, 10/07/09 Relevance Score: 89%

Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: Effects of rituximab
Annals of Oncology, 11/10/09 Relevance Score: 88%

Prevention of hepatitis B virus reactivation under rituximab therapy
Immunotherapy, 11/06/09 Relevance Score: 88%

Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy
Annals of Oncology, 11/06/09 Relevance Score: 87%